Treatment research status of branch retinal vein occlusion / 眼科新进展

ABSTRACT

Retinal vein occlusion (RVO) is the second common retinal vascular disease after diabetic retinopathy,which is divided into central retinal vein occlusion and branch retinal vein occlusion (BRVO).The current specific pathogenisis of BRVO is remain unclear and the incidence rate has been increases year by year.BRVO often causes macular edema (ME),and recurrent ME can lead to a permanent decline in vision.Traditional treatment includes grid laser photocoagulation and glucocorticoid drugs represented by traimcinolone and dexamethasone.In recent years,anti-vascular endothelial growth factor drugs and vitrectomy have developed,and become new treatment methods for BRVO.This paper will give a review on the recent advances in the treatment methods of BRVO.